• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problems Off-Label Use (1494); Incomplete Coaptation (2507)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/28/2024
Event Type  malfunction  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Attachment: article titled "same-day discharge following elective transcatheter edge-to-edge repair".Na.
 
Event Description
This research article was a retrospective study designed to evaluate the outcomes after same-day discharge (sdd) in patients who underwent transcatheter edge-to-edge repair (teer).Complications identified in the study included: single leaflet device attachment (slda), life-threatening bleeding, vascular complication, acute kidney injury, mitral or tricuspid reintervention, readmission due to heart failure, and all-cause mortality.In conclusion, in this single-center retrospective analysis, sdd after teer was feasible with comparable safety outcomes with non-sdd.Patients undergoing isolated tteer, combined mitral and tricuspid teer, or afternoon procedures were more likely to have a delayed discharge (>1 day).As teer continues to become widely adopted, the sdd pathway is likely to be more commonly implemented.A larger prospective study is ongoing to further evaluate the safety and efficacy of the sdd approach.Details are listed in the attached article titled, "same-day discharge following elective transcatheter edge-to-edge repair".
 
Manufacturer Narrative
The device was not returned for analysis and a review of the lot history record and similar complaint review could not be performed as the part and lot number regarding the complaint device was not provided.The investigation was unable to determine a cause for the reported hemorrhage, renal failure, heart failure, and death.Hemorrhage, renal failure, heart failure, and death are listed in the instructions for use as known possible complications associated with the mitraclip procedures.The reported hospitalization and unexpected medical interventions were results of case specific circumstances.The reported off-label use was due to the device being used on a tricuspid valve.There is no indication of a product issue with respect to manufacture, design, or labeling.Literature attachment: article title "same-day discharge following elective transcatheter edge-to-edge repair".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18950823
MDR Text Key338442123
Report Number2135147-2024-01283
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/28/2024
Initial Date FDA Received03/21/2024
Supplement Dates Manufacturer Received04/02/2024
Supplement Dates FDA Received04/18/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age79 YR
Patient SexMale
-
-